Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Norepinephrine Bitartrate Injection

Approval Number

国药准字H20217065

Company远大医药（中国）有限公司

Registration Date

July 30, 2021

Previous Approval Numbers

国药准字H42021301

Drug Information

Generic Name

重酒石酸去甲肾上腺素注射液

Dosage Form

注射剂

Strength

4ml:8mg

Drug Type

化学药品

Registration Date

July 30, 2021

Company Information

Applicant Company

Company Name远大医药（中国）有限公司

Company Address

硚口区硚口路160号1幢23层1-6号

Manufacturing Company

Company Name远大医药（中国）有限公司

Company Address

湖北省武汉市东西湖区金银湖生态园环湖中路11号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy